Top Biotech Stocks Next Week Trading Opportunities (PRVB, SRPT, ALNY, VIR, BCRX)
Signals from Pattern Search Engine
Tickeron is bringing high-powered Artificial Intelligence (A.I.) technology to the retail investment community that, in our opinion, rivals the technology and approach used at major Wall Street firms. The Ph. D founders of Tickeron have spent several years researching and building an Artificial Intelligence-based search engine that allows active investors to perform thousands of hours of research and pattern searches...in just minutes.
A security pattern traces distinct movements of security prices that, once recognized, helps investors make informed trading decisions. Patterns are identified by their key geometrical elements, formed by changing security prices.
Every day Artificial Intelligence analyses 39 patterns for 8000 stocks, 3000 ETFs, most popular Crypto & Forex pairs and presents trading ideas with backtest and statistic results.
BUY signal for PRVB (Broadening Wedge Ascending)
The Broadening Wedge Ascending pattern forms when the price of a security progressively makes higher highs (1, 3) and higher lows (2, 4), following two widening trend lines. This pattern may form when large investors spread their buying over a period of time.
The theory goes that after initial buying occurs, other market participants react to the rising price and jump on the bandwagon to participate. Then value investors begin to sell, believing the price has risen too much, which spurs the original large investor to resume buying again.
Trade Idea:
BUY near the Breakout (Entry) price – $9.95
SELL at the Target (Exit) price – $11.08
Subscribe and get 14-days free trial
Signals from Trend Prediction Engine
Trend trading is a strategy based on the technical analysis of changing market prices. The trend trader enters into a long position when a stock is trending upward and uses the short position when a stock is trending downward.
Tickeron's End-of-Day Trend Prediction Engine will instantly generate AI-driven projections on whether a stock is going up or down for the next week or month. The algorithm looks at past price changes and generates unique insights into future fluctuations. TPE analyzes trends for stocks, penny stocks, ETFs, mutual funds, cryptocurrencies, and Forex. To make this tool more convenient, it’s best to customize it by adjusting the confidence level, price range, asset classes, and many others. You can also set up notifications for emails or push notifications.
BUY signals for SRPT, ALNY, VIR
Trade Idea:
BUY at the opening of the Stock Market on Monday if the opening price has gone up by no more than 0.5% of the closing price of Friday.
SELL after the price has risen by 2% from the closing price on Friday, or at the end of the trading week if the target is not reached.
Subscribe and get a 14-days free trial
Signals from Buy/Sell Analytical System
Buy/Sell recommendations is a complex analytical system consisting of several blocks:
TA score - signals from several technical indicators (MACD, RSI, Stochastic, etc.) are processed using neural networks.
FA score - complex fundamental analysis based on quantitative comparative ratings (Valuation, P/E Growth, SMR etc.)
Buy / Sell rating system - processes the aggregate score results and generates a trading signal.
BUY signal for BCRX
Trade idea:
Step 1. BUY BCRX at the current market price.
Step 2. Set up alerts for BCRX from Buy/Sell Analytical System.
Step 3. SELL BCRX after receiving the "SELL" recommendation.
VIR in upward trend: price rose above 50-day moving average on January 13, 2026
VIR moved above its 50-day moving average on January 13, 2026 date and that indicates a change from a downward trend to an upward trend. In of 37 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on January 13, 2026. You may want to consider a long position or call options on VIR as a result. In of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for VIR just turned positive on January 13, 2026. Looking at past instances where VIR's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .
The 10-day moving average for VIR crossed bullishly above the 50-day moving average on January 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where VIR advanced for three days, in of 257 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VIR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
VIR broke above its upper Bollinger Band on January 13, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for VIR entered a downward trend on January 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VIR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.084) is normal, around the industry mean (27.497). P/E Ratio (0.000) is within average values for comparable stocks, (51.030). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.892). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (60.976) is also within normal values, averaging (323.026).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VIR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases
Industry Biotechnology
Advertisement